Performance characteristics of a quantitative, homogeneous TaqMan RT-PCR test for HCV RNA

Area of Science:

• Molecular Biology
• Virology
• Diagnostic Assays

Background:

• Accurate quantification of hepatitis C virus (HCV) RNA is crucial for patient management.
• Existing methods may have limitations in sensitivity, specificity, or broad genotype applicability.

Purpose of the Study:

• To develop and validate a homogeneous reverse transcription-polymerase chain reaction (RT-PCR) assay for quantitative HCV RNA detection.
• To assess the assay's performance characteristics, including limit of detection, linearity, reproducibility, and specificity.

Main Methods:

• Utilized TaqMan technology with dual-probe system for simultaneous detection of HCV RNA and an internal control.
• Employed a standardized external standard curve for quantification in international units (IU)/ml.
• Evaluated performance across different HCV genotypes and assessed specificity against common co-infecting pathogens.

Main Results:

• Established a limit of detection of 40 IU/ml with 95% sensitivity at 28 IU/ml.
• Demonstrated equal amplification efficiency and accurate quantification across all HCV genotypes.
• Exhibited a wide linear range (64 to 4,180,000 IU/ml) and excellent reproducibility (CV 21.6-30.4%).
• Achieved 99% specificity in seronegative blood donors and showed no cross-reactivity with other viruses.
• Successfully differentiated treatment responders from non-responders based on viral load dynamics.

Conclusions:

• The TaqMan quantitative HCV assay is a sensitive, specific, and reproducible tool for measuring HCV viral load.
• This assay offers a reliable alternative for prognosis and monitoring antiviral therapy efficacy.
• The ability to accurately quantify viral load across genotypes enhances its clinical utility for diverse patient populations.